0 Комментарии
0 Поделились
704 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
CAR-NK Cell Therapy Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033" According to the latest report published by Data Bridge Market Research, the CAR-NK Cell Therapy Market The global CAR-NK cell therapy market size was valued at USD 346.5 Million in 2025 and is expected to reach USD 1,004.50 Million by 2033, at a CAGR of 14.20% during the forecast period The market growth is largely fueled by increasing investments in...0 Комментарии 0 Поделились 90 Просмотры 0 предпросмотр
-
CAR-T Cell Therapy Market Driven by Growing Demand for Targeted ImmunotherapiesThe global oncology industry is rapidly transforming with the adoption of advanced immunotherapy solutions, making the CAR-T Cell Therapy Market one of the fastest-growing sectors in cancer treatment. Chimeric antigen receptor T-cell therapies are revolutionizing the treatment landscape for hematologic malignancies by utilizing genetically modified T cells to target and destroy cancer cells....0 Комментарии 0 Поделились 400 Просмотры 0 предпросмотр
-
CAR-T Cell Therapy Market Share Increasing with Growing Adoption of Personalized Cancer TreatmentsThe global orthopedic sector is witnessing substantial growth with increasing adoption of advanced hip replacement technologies, making the Acetabular Prostheses Market a critical segment within orthopedic implant solutions. Acetabular prostheses are extensively used during hip replacement surgeries to restore mobility, reduce chronic pain, and improve overall quality of life for patients...0 Комментарии 0 Поделились 634 Просмотры 0 предпросмотр
-
China Immunotherapy Drugs Market: How Is CAR-T Cell Therapy Developing in China?China CAR-T cell therapy market — the rapidly developing cellular immunotherapy sector in China encompassing both approved CAR-T products and the world's most extensive CAR-T clinical trial pipeline — creates a distinct and commercially significant segment within the Chinese immunotherapy market, with the China Immunotherapy Drugs Market reflecting CAR-T therapy as the most...0 Комментарии 0 Поделились 742 Просмотры 0 предпросмотр
-
Global CAR-NK Cell Therapy Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033The global CAR-NK cell therapy market size was valued at USD 346.5 Million in 2025 and is expected to reach USD 1,004.50 Million by 2033, at a CAGR of 14.20% during the forecast period The market growth is largely fueled by increasing investments in advanced immunotherapies, rising prevalence of cancer, and continuous technological progress in genetic engineering...0 Комментарии 0 Поделились 159 Просмотры 0 предпросмотр
-
Rising Investments in Cancer Research Supporting CAR-T Cell Therapy Market Growth WorldwideThe global oncology industry is rapidly transforming with the adoption of advanced immunotherapy solutions, making the CAR-T Cell Therapy Market one of the fastest-growing sectors in cancer treatment. Chimeric antigen receptor T-cell therapies are revolutionizing the treatment landscape for hematologic malignancies by utilizing genetically modified T cells to target and destroy cancer cells....0 Комментарии 0 Поделились 486 Просмотры 0 предпросмотр
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. A team involved in preparing this Blood Cancer Market research report has kept certain things into...0 Комментарии 0 Поделились 623 Просмотры 0 предпросмотр
-
CAR T-Cell Therapy & Immune Checkpoint InhibitorsTwo of the most transformative advances in modern oncology are CAR T-Cell Therapy and Immune Checkpoint Inhibitors. Both harness the immune system to fight cancer, but they do so through fundamentally different mechanisms. Checkpoint inhibitors are off-the-shelf antibodies that release the brakes on the immune system, enabling pre-existing T cells to attack tumors. CAR T-cell...0 Комментарии 0 Поделились 377 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek